|

Value of Pleural Lavage Cytology in Resectable Esophageal Carcinoma Eastern Cooperative Thoracic Oncology Projects 2005, ECTOP-2005)

RECRUITINGSponsored by Fudan University
Actively Recruiting
SponsorFudan University
Started2022-07-18
Est. completion2024-07-01
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05443841

Summary

Disease recurrence and metastasis are common after curative treatment for patients with esophageal cancer. Thus, it is important to identify the risk factors to predict disease recurrence and metastasis. Pleural lavage cytology (PLC) is reported to be associated with disease recurrence and patient survival in lung cancer, but the value is unclear in esophageal cancer. The aim of this study is to evaluate the value of PLC in esophageal cancer patient in terms of frequencies, association with patient survival, and efficacy of postoperative treatment.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* esophageal cancer with histological confirmation before treatment.
* resectable esophageal cancer with clinical T1-4a/N0-3/M0 staging
* potential R0 resection
* no history of other malignancies

Exclusion Criteria:

* severe major organ dysfunction (American society of anesthesiologisits score \>3 )
* patients underwent ESD or EMR
* pleural lavage is unavailable due to adhesions

Conditions2

CancerEsophageal Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.